Peptide Dosage Chart
A peptide dosage chart for 43 research compounds, grouped by goal. Each row shows the dose ranges reported in research protocols, how often they are given and typical cycle length, with a link to the full guide for reconstitution, stacking and research notes.
Weight Loss & Fat Loss peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| 5-Amino-1MQMetabolic / Body Composition | Maintenance / Lower Range500 mcg (2.5 units)Advanced / Higher Range1 mg (5 units) | Once daily, morning · subcutaneous · suggested cycle 6–8 weeks. |
| AOD-9604Body Composition / Metabolic | Maintenance / Lower Range250 mcg (10 units)Advanced / Higher Range500 mcg (20 units) | Once daily, morning · subcutaneous · suggested cycle 12–16 weeks ON, 2–4 weeks OFF. |
| CagrilintideMetabolic / Appetite Control | Conservative Starting Range500 mcg (10 units)Moderate Range1 mg (20 units)Advanced Range2 mg (40 units)Higher / Experienced Range3 mg (60 units) | Once weekly · evaluate appetite response and tolerability before increasing. |
| MazdutideMetabolic / Body Composition | Starting Dose1 mgStandard Range2–4 mg per weekHigher Range4–6 mg per week | 1–2× per week for approximately 3–4 weeks while evaluating sensitivity. |
| RetatrutideTriple Agonist (GLP-1 / GIP / Glucagon) | Weeks 1–20.5 mgWeeks 3–40.8 mg per injectionTypical Working Dose1.0 mg per injection | Administered Monday/Wednesday/Friday (weekly total 1.5 mg) · focus on hydration, protein consistency, and monitoring nausea/GI response. |
| SLU-PP-332ERR Agonist / Exercise Mimetic | Standard Research Dose1 tablet (1000 mcg) | Twice daily · sublingual — allow to fully dissolve under the tongue before swallowing. |
| TesofensineSNDRI / Appetite Suppression | Provided Research Reference500 mcg | Once daily · oral · long half-life means once-daily dosing is sufficient per source material. |
Muscle Growth & Performance peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| CJC-1295 + IpamorelinGHRH + GHRP / Growth Hormone Axis | Provided Research Reference500 mcg + 500 mcg – 1 mg + 1 mg | Once daily, in the PM before bed · subcutaneous, typically in the abdomen. |
| FLGR-242 (Follistatin)Myostatin / Activin Pathway Research | Phase 12.5 mg every other weekPhase 2 (if continuing)2.5 mg per week | For 6–8 weeks, per the source community protocol. |
| HGHDirect Hormone Replacement (Recombinant Somatropin) | Anti-Aging / Wellness1–2 IU dailyBody Recomposition2–4 IU daily | 5–7 days per week · before bed or fasted morning · long-term or cycled (6 months on, 2 months off). |
| IGF-1 LR3Muscle Growth / Performance / Recovery | Lower Range50 mcg (5 units)Standard Range100 mcg (10 units)Advanced Range150 mcg (15 units) | Once daily · subcutaneous or intramuscular. |
| IpamorelinGrowth Hormone Axis / Recovery | Standard / Lower Range500 mcg (5 units)Advanced Range1 mg (10 units) | Once daily · subcutaneous administration. |
| SermorelinGHRH / Growth Hormone Axis | Provided Research Reference500 mcg–1 mg (5–10 units) | Once daily · subcutaneous · the source protocol notes it is best used alongside a GHRP. |
| TesamorelinBody Composition / Growth Hormone Axis | Provided Research Reference500 mcg–1 mg | Daily · subcutaneous · the source protocol describes 4–5 months ON, 4 weeks OFF, then reassess. |
Injury Recovery & Healing peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| ARA-290Recovery / Nerve & Inflammation | Maintenance / Lower Range2 mg (20 units)Advanced / Higher Range4 mg (40 units) | Once daily · subcutaneous · suggested research cycle 4–12 weeks. |
| BPC-157Healing / Recovery / Anti-Inflammation | Maintenance / Lower Range500 mcg (10 units)Advanced / Loading Range1 mg (20 units) | Once daily · subcutaneous · 5 days ON / 2 days OFF or every other day. |
| CartalaxJoint Health / Connective Tissue / Bioregulator | Moderate Recovery1 mg (10 units)Advanced / Severe Recovery2 mg (20 units) | Once daily · 5 days ON / 2 days OFF · suggested cycle 4 weeks, then 1–2 months off. |
| GHK-CuRejuvenation / Healing | Standard Range2.5–5.0 mg (5–10 units) | 3–5× per week · subcutaneous administration. |
| KPVHealing / Recovery / Anti-Inflammation | Standard / Lower Range500 mcg (5 units)Advanced Range1 mg (10 units) | Once daily · subcutaneous · 5–7× per week. |
| MGFMuscle Repair / Growth Signaling | See full guide | Protocol details on the compound page. |
| TB-500Healing / Recovery / Tissue Remodeling | Provided Research Reference500 mcg–1 mg (5–10 units) | Either vial size, once dosed, can be split into 5 days ON / 2 days OFF or spread across 3 injections per week. |
| Thymosin Alpha-1Immunity / Anti-Inflammation | Suggested Range1–1.5 mg | Daily to every other day · subcutaneous administration. |
Anti-Aging & Longevity peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| EpitalonAnti-Aging / Sleep / Longevity | Standard 20-Day Protocol5 mg (20 units)Higher-Dose 10-Day Protocol10 mg (40 units) | Once daily · subcutaneous · evening/nighttime · 20 consecutive days. |
| KlothoLongevity / Cardiovascular / Cellular Health | Standard Research Protocol5 mcg (50 units) | Every 2 weeks · subcutaneous — periodic rather than daily administration. |
| MOTS-CMitochondrial Health / Metabolic Support | Standard Research Protocol1 mg (10 units) | Subcutaneous · either daily or 5 days ON / 2 days OFF. |
| NAD+Rejuvenation / Cellular Energy | Standard NAD+ Research Protocol5–25 mg per administration | Subcutaneous or intramuscular · 3–5× per week. Start at 5 mg and increase by ~5 mg per administration as tolerated. |
| SS-31Mitochondrial Health / Cellular Energy | Standard Research Dose1 mg (10 units)Higher Research Dose1.5 mg (15 units) | Daily · 5 days ON / 2 days OFF · subcutaneous. |
Skin, Hair & Beauty peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| GlutathioneGeneral Health / Antioxidant / Cellular Support | Standard Protocol200–400 mgLower-Dose Daily Protocol100 mg (≈46 units, alt. mix) | Subcutaneous or intramuscular · 3× per week · suggested cycle 4–8 weeks, then ~4 weeks off. |
| Melanotan IMelanocortin / Skin Pigmentation | Beginner Range500 mcg (10 units)Active Tanning Phase1 mg (20 units)Advanced Range1.5–2 mg (30–40 units) | Common starting dose to assess tolerance. |
| Melanotan IIMelanocortin / Skin Pigmentation | Beginner Range250 mcg (5 units)Loading / Maintenance500 mcg (10 units)Advanced Range750 mcg–1 mg (15–20 units) | Common starting dose used to assess tolerance. |
Cognition, Focus & Mood peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| CerebrolysinNootropic / Neurotrophic Support | Standard Research Protocol5 mg (50 units) | Once daily · intramuscular · suggested cycle 30 consecutive days, up to 4 cycles per year. |
| DihexaNeurotrophic Compound | Foundational Protocol10 mg (1 tablet) | Once daily · morning or a pre-work cognitive-demand window is preferred. |
| Methylene BlueMitochondrial / Cognitive Support | Beginner10 mg (½ tablet)Standard20 mg (1 tablet)Advanced20 mg, 1–2× daily | Once daily. |
| PinealonNootropic / Cognitive Health | Maintenance Protocol (Ages 30–40+)10 mg dailyCognitive Support Protocol (Ages 50+)10 mg daily | 10-day protocol, repeated approximately 2–3 times per year. |
| SelankNootropic / Anxiolytic Research | Typical Research Range250–500 mcg per dose | 1–3× daily · most commonly administered intranasally. |
| SemaxNootropic / Neurological Health | Typical Research Range250–500 mcg per dose | 1–3× daily · most commonly administered intranasally. |
Sexual Health & Libido peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| HCGHormonal Support / Male Fertility / TRT Support | Fertility / Testicular Support500–1,000 IU per administrationTRT Support500 IUPost-Cycle Protocol1,000 IU | ~3× per week (e.g. Mon/Wed/Fri) · subcutaneous. |
| KisspeptinHormonal Support / Reproductive Health | Standard / Lower Range500 mcg (5 units)Advanced Range1 mg (10 units) | Subcutaneous · 3–5× per week. |
| OxytocinBonding / Emotional & Sexual Wellness | Provided Research Reference150–350 mcg (≈5–10 units) | Subcutaneous · as needed. |
| PT-141Melanocortin / Sexual Function | Men1 spray each nostril (100 mcg per spray)Women1 spray, one nostril | 30 minutes to 1 hour before activity · intranasal. |
Immune Support peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| BronchogenBioregulator / Respiratory Health | Suggested Research Protocol2 mg | Daily for 30 straight days (continue for 4 weeks). |
| LL-37Immunity / Antimicrobial | Provided Research Reference225–500 mcg (5–10 units) | Once daily, AM · subcutaneous, belly fat or thigh. |
Sleep & Relaxation peptides
| Compound | Research dose range | Frequency & cycle |
|---|---|---|
| DSIPSleep / Recovery | Lower / Maintenance Range250–500 mcg (2.5–5 units)Advanced Range1–2 mg (10–20 units) | 30–60 minutes before bedtime · subcutaneous · daily or as needed. |
No peptide matches that search. Try the Signal Library or ask Pulse.
Frequently asked questions
What is a peptide dosage chart?
It is a quick-reference table of the dose ranges, frequency and cycle lengths reported in research protocols for each peptide. It summarises the detailed guides on Signal IQ; always read the full compound page before relying on any number.
How many units is a peptide dose?
Units depend on concentration. On a U-100 insulin syringe, 100 units equal 1 mL, so the number of units for a given mcg dose depends on how much bacteriostatic water was added to the vial. The units in this chart assume each compound page’s reconstitution.
What is the difference between mcg and mg?
1 mg equals 1,000 mcg. Many peptides are dosed in micrograms (for example 250 mcg), while vials are labelled in milligrams (for example 5 mg), so converting carefully avoids tenfold errors.
Why do peptides have a lower and a higher range?
Research protocols usually start at a lower dose to assess tolerance and only increase if needed. The higher range is reserved for more experienced protocols and is not a target.
Do peptides need to be cycled?
Many protocols run in cycles with time off between them. Cycle lengths in this chart come from each compound’s guide; see peptide cycling for the reasoning.
Educational content only. These figures summarise research protocols and literature. They are not medical advice or a recommendation to use any compound, and many of these peptides are not approved for human use. Work with a qualified clinician. Signal IQ does not sell peptides.